Is there a role for sentinel lymph node biopsy in the management of sarcoma?
dc.contributor.author | Blazer, Dan G. | |
dc.contributor.author | Sabel, Michael S. | |
dc.contributor.author | Sondak, Vernon K. | |
dc.date.accessioned | 2006-06-15T12:55:21Z | |
dc.date.available | 2006-06-15T12:55:21Z | |
dc.date.issued | 2003 | |
dc.identifier.citation | Surgical Oncology, vol 12, 2003, 201-206. <http://hdl.handle.net/2027.42/39196> | en |
dc.identifier.uri | https://hdl.handle.net/2027.42/39196 | |
dc.description | A review of the role for sentinel lymph node biopsy in sarcoma. | en |
dc.description.abstract | Is there a role for sentinel lymph node (SLN) biopsy in the management of sarcoma? Sentinel node biopsy has dramatically changed the management of melanoma and breast cancer, helping surgeons avoid radical lymphadenectomies in node negative patients who would previously have undergone a more morbid operation with little benefit, or remained pathologically unstaged. Many investigators have explored the use of lymphatic mapping for malignancies other than breast cancer or melanoma. Lymphatic mapping and sentinel node biopsy has not been investigated in the management of sarcomas, which is not surprising given that the majority of sarcomas spread by local extension or hematogenously. Regional lymph node metastases are rare; developing in about 3–10% of patients with localized disease. However, among certain subtypes of high-grade sarcomas there is a propensity for regional lymph node metastases. These include rhabdomyosarcoma, epithelioid sarcoma, clear cell sarcoma, synovial sarcoma, and vascular sarcomas. It is in these particular subtypes that there may be a benefit to SLN biopsy. | en |
dc.format.extent | 253831 bytes | |
dc.format.mimetype | application/pdf | |
dc.language.iso | en_US | en |
dc.publisher | Elsevier | en |
dc.subject | Sarcoma | en |
dc.subject | Sentinel Lymph Node Biopsy | en |
dc.title | Is there a role for sentinel lymph node biopsy in the management of sarcoma? | en |
dc.type | Article | en |
dc.subject.hlbsecondlevel | Oncology and Hematology | |
dc.subject.hlbsecondlevel | Surgery and Anesthesiology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | en |
dc.contributor.affiliationum | Surgical Oncology, Division of | en |
dc.contributor.affiliationumcampus | Ann Arbor | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/39196/1/sarcoma SLN.pdf | en_US |
dc.identifier.source | Surgical Oncology | en_US |
dc.owningcollname | Surgical Oncology Review Articles |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.